BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Sandu Pharmaceuticals Ltd. Share Price

NSE
BSE

BSE : 524703

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 671.92 140.69
Expenses N/A N/A
PBT 21.56 3.42
Operating profit 0.0 0.0
Net profit 15.49 3.26

Shareholding Pattern

Promoters (% Holding)

37.79%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

62.21%

FI/Banks/Insurance (% Holding)

0.01%

Government (% Holding)

0.00%

FII

0.00%

About Sandu Pharmaceuticals Ltd.

Founded 1985

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,41,789.55 1,841.30 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,79,450.12 6,794.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,54,733.87 4,571.90 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,20,848.85 8,419.00 6,696.50 - 6,696.50
Cipla Ltd. 1,14,182.61 1,413.00 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,11,184.65 1,334.10 1,148.40 - 1,148.40
Zydus Lifesciences Ltd. 1,07,973.94 1,073.05 835.50 - 835.50
Lupin Ltd. 1,04,613.28 2,291.00 1,836.80 - 1,836.80
Mankind Pharma Ltd. 1,01,443.53 2,461.50 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 97,382.77 1,000.60 903.00 - 903.00
no-content No Records Found

Latest News

May
18
2026
EQUITY Posted on May 18th 2026

Sandu Pharmaceuticals informs about compliance report

Sandu Pharmaceuticals has informed that it enclosed Annual Secretarial Compliance Report for the year ended 31 March 2026 issued by CS Swapnil JDixit, Practising Company Secretary.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
21
2026
EQUITY Posted on Mar 21st 2026

Sandu Pharmaceuticals informs about trading window closure

Sandu Pharmaceuticals has informed that trading window for dealing in Securities of the Company shall remain closed from Wednesday, 01 April 2026 till 48 hours after the declaration of the financial results of the Company for the quarter and year ended 31st March 2026 for Directors, KMPs, Promoters And Promoters Group and Designated Persons, Immediate Relative etc covered under the Code. The date of the Board Meeting for consideration of the Audited Financial Results of the Company for the Quarter and Year ended 31 March 2026 will be intimated in due course. Accordingly, all Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid trading window closure period.
The above information is a part of company’s filings submitted to BSE.
Read More
May
25
2026
EQUITY Posted on May 25th 2026

Rainbow Children's Medicare informs about press release

Rainbow Children's Medicare has informed that it attached copies of newspaper advertisement of Financial Results of the Company for the Quarter and Financial Year ended March 31, 2026, published in Business Standard (All India edition) and Mana Telangana (Telugu edition) on May 25, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
25
2026
EQUITY Posted on May 25th 2026

Mangalam Drugs & Organics informs about secretarial compliance report

In terms of provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, Mangalam Drugs & Organics has informed that it enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE. 

Read More
May
25
2026
EQUITY Posted on May 25th 2026

Star Imaging And Path Lab informs about investor presentation

Star Imaging And Path Lab has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to the intimation dated 19 May 2026 regarding schedule of Analyst(s)/ Investor(s) Meet /Conference, Earnings Call on Monday, 25 May 2026 at 3:00 pm (IST), We are hereby enclosing a copy of Investor Presentation based on the Audited (Standalone and Consolidated) Financial results of the Company for Half and Financial year ended 31st March 2026. The Investor Presentation are also being made available on the Company’s website at www.Starimaging.in .
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Sandu Pharmaceuticals Ltd. ?

The current share price of Sandu Pharmaceuticals Ltd. is ₹39.96 as of 2026-05-25.

The market capitalisation of Sandu Pharmaceuticals Ltd. is ₹38.61 as of 2026-05-25.

The 1-year return of Sandu Pharmaceuticals Ltd. is -15.04% as of 2026-05-25.

The P/E ratio of Sandu Pharmaceuticals Ltd. is 30.50 as of 2026-05-26.

The 52-week high and low of Sandu Pharmaceuticals Ltd. are ₹58.80 and ₹30.00, respectively, as of 2026-05-25.

The dividend yield of Sandu Pharmaceuticals Ltd. is 2.5025% as of2026-05-25.

You can buy Sandu Pharmaceuticals Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Sandu Pharmaceuticals Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore